TP53 and cancer: The iron equilibrium could represent a part of defense against cancer operated by p53, as demonstrated in p53-deficient mouse-liver models of hepatocellular carcinoma displaying a status of iron deficiency associated with low hepcidin and a high transferrin receptor signature [155].